| CYSL0500005 | 30/70双时相低精蛋白锌重组人胰岛素注射液 | human insulin;isophane protamine human insulin | Injection | Biological Products(15) | Generic Drug | 2005-08-24 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2006-07-12 | view |
| CYSS0690004 | 30/70双时相低精蛋白锌重组人胰岛素注射液 | human insulin;isophane protamine human insulin | Injection | Biological Products(15) | Generic Drug | 2006-10-23 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2010-03-11 | view |
| CYSS0600071 | 30/70双时相低精蛋白锌重组人胰岛素注射液 | human insulin;isophane protamine human insulin | Injection | Biological Products(15) | Generic Drug | 2006-08-08 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2007-09-19 | view |
| CXHL2300698 | VS-H101注射液 | VS-H101 | Injection | Chemical Drugs(1) | New Drug Application | 2023-06-27 | | Wanbang Biopharmaceuticals | | | view |
| CXHB2000028 | 丁二酸复瑞替尼胶囊 | SAF-189s | Capsule | Chemical Drugs | Supplementary Application | 2020-04-15 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-04-14 | view |
| CXHB2000027 | 丁二酸复瑞替尼胶囊 | SAF-189s | Capsule | Chemical Drugs | Supplementary Application | 2020-04-15 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-04-14 | view |
| CXHL1700350 | 万格列净 | | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-01-31 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-01-29 | view |
| CXHL1700351 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXHL1700353 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXHL1700352 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| Y0303121 | 中性胰岛素注射液 | | Injection | Chemical Drugs | Supplementary Application | 2003-09-06 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2004-03-19 | view |
| Y0414184 | 中性胰岛素注射液 | | Injection | Chemical Drugs | Supplementary Application | 2004-11-10 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Filed | 2004-10-18 | view |
| CYHB0906883 | 中性胰岛素注射液 | | Injection | Chemical Drugs | Supplementary Application | 2009-07-24 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2009-12-11 | view |
| Y0300297 | 中性胰岛素注射液 | | Injection | Chemical Drugs | Supplementary Application | 2003-03-11 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2003-09-24 | view |
| CSS00070 | 中性重组人胰岛素注射液 | | Injection | Biological Products(2) | New Drug Application | 2000-09-28 | 徐州万邦生化制药有限公司 | Wanbang Biopharmaceuticals | Approval Completed-Pending Certificated | 2002-01-14 | view |
| CYSB2300060 | 人胰岛素注射液 | human insulin | Injection | Biological Products(3.3) | Supplementary Application | 2023-03-11 | | Wanbang Biopharmaceuticals | | | view |
| CYSB2400057 | 人胰岛素注射液 | human insulin | Injection | Biological Products(3.3) | Supplementary Application | 2024-03-01 | | Wanbang Biopharmaceuticals | | | view |
| CYHS0505619 | 伏格列波糖 | voglibose | Active ingredient | Chemical Drugs(6) | Generic Drug | 2005-07-25 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2007-11-12 | view |
| CXHL0501515 | 伏格列波糖分散片 | voglibose | Tablet | Chemical Drugs(5) | New Drug Application | 2005-07-25 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2009-06-11 | view |
| CXHL0501516 | 伏格列波糖胶囊 | voglibose | Capsule | Chemical Drugs(5) | New Drug Application | 2005-07-25 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2009-03-30 | view |
